We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$130B
AUM Growth
+$12.3B
Cap. Flow
+$1.54B
Cap. Flow %
1.18%
Top 10 Hldgs %
17.24%
Holding
8,628
New
1,223
Increased
3,315
Reduced
2,707
Closed
1,164

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$548M
2
MU icon
Micron Technology
MU
+$461M
3
C icon
Citigroup
C
+$334M
4
AVGO icon
Broadcom
AVGO
+$319M
5
ABBV icon
AbbVie
ABBV
+$267M

Sector Composition

Rank Sector Weight
1 Technology 7.23%
2 Financials 5.58%
3 Industrials 4.98%
4 Consumer Discretionary 4.95%
5 Healthcare 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LJPC
5301
CALL
DELISTED
La Jolla Pharmaceutical Company
LJPC
$459K ﹤0.01%
13,200
-1,700
-11% -$54.7K
DWT
5302
DELISTED
VelocityShares 3x Inverse Crude Oil ETNs linked to the S&P GSCI Crude Oil Index ER
DWT
$459K ﹤0.01%
19,918
+508
+3% +$14.6K
ALKS icon
5303
PUT
Alkermes
ALKS
$8.23B
$458K ﹤0.01%
9,000
+3,300
+58% +$176K
AMAG
5304
PUT
DELISTED
AMAG Pharmaceuticals
AMAG
$458K ﹤0.01%
24,800
+5,800
+31% +$108K
UNIT
5305
CALL
Uniti Group
UNIT
$2.43B
$457K ﹤0.01%
31,200
+20,000
+179% +$422K
NVGS icon
5306
CALL
Navigator Holdings
NVGS
$1.29B
$456K ﹤0.01%
+41,100
New +$426K
PBT
5307
Permian Basin Royalty Trust
PBT
$1.52B
$456K ﹤0.01%
52,353
-3,043
-5% -$26.4K
ARLP icon
5308
Alliance Resource Partners
ARLP
$3.27B
$455K ﹤0.01%
23,526
-12,377
-34% -$237K
KWEB icon
5309
PUT
KraneShares CSI China Internet ETF
KWEB
$5.35B
$455K ﹤0.01%
+8,000
New +$436K
MITK icon
5310
Mitek Systems
MITK
$877M
$454K ﹤0.01%
+47,791
New +$467K
GLOP
5311
DELISTED
GASLOG PARTNERS LP
GLOP
$454K ﹤0.01%
19,508
+9,896
+103% +$232K
DNB
5312
PUT
DELISTED
Dun & Bradstreet
DNB
$454K ﹤0.01%
3,900
-600
-13% -$66.6K
ACHN
5313
DELISTED
Achillion Pharmaceuticals
ACHN
$453K ﹤0.01%
101,018
-80,951
-44% -$359K
XPP icon
5314
CALL
ProShares Ultra FTSE China 50 of PROSHARES TRUST
XPP
$8.31M
$452K ﹤0.01%
6,100
+1,600
+36% +$113K
BJRI icon
5315
CALL
BJ's Restaurants
BJRI
$1.45B
$451K ﹤0.01%
14,800
+8,900
+151% +$288K
RMBS icon
5316
PUT
Rambus
RMBS
$10.9B
$451K ﹤0.01%
33,800
+4,200
+14% +$54K
GWR
5317
PUT
DELISTED
Genesee & Wyoming Inc.
GWR
$451K ﹤0.01%
6,100
-5,800
-49% -$397K
CCOI icon
5318
CALL
Cogent Communications
CCOI
$579M
$450K ﹤0.01%
9,200
-3,800
-29% -$168K
EGP icon
5319
EastGroup Properties
EGP
$10.9B
$449K ﹤0.01%
5,094
-154,412
-97% -$13.3M
EWC icon
5320
CALL
iShares MSCI Canada ETF
EWC
$6.56B
$449K ﹤0.01%
15,500
+1,000
+7% +$27.8K
SPPI
5321
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$449K ﹤0.01%
+31,900
New +$289K
CHMI
5322
Cherry Hill Mortgage Investment Corp
CHMI
$108M
$447K ﹤0.01%
24,696
-1,016
-4% -$19K
DEM icon
5323
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
$447K ﹤0.01%
10,401
+828
+9% +$35.7K
WST icon
5324
West Pharmaceutical
WST
$24.6B
$447K ﹤0.01%
4,643
-22,429
-83% -$2.03M
CEQP
5325
CALL
DELISTED
Crestwood Equity Partners LP
CEQP
$447K ﹤0.01%
18,300
+5,700
+45% +$140K

Similar funds

Ken Griffin's Q3 2017 Portfolio in Review

As of Q3 2017, Ken Griffin held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Ken Griffin's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.

By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.4% a quarter earlier, followed by Financials and Industrials.

  • Ken Griffin's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
  • Ken Griffin added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
  • Ken Griffin's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
  • Ken Griffin fully exited Citigroup in Q3 2017, selling an estimated $334M.
  • Ken Griffin's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
  • Ken Griffin opened 1,223 new positions and closed 1,164 in Q3 2017.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $130B.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.